Gene · 9097
Papers1,667
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,667
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting USP14 sensitizes glioma to radiotherapy through exacerbated reactive oxygen species accumulation. | Med Gas Res | 2027 | 42734450 | PubTator, text mining | PubMed |
| CD81 drives immune evasion in radioresistant glioblastoma by blocking selective autophagic degradation of CD274/PD-L1. | Autophagy | 2026 | 42733113 | PubTator, text mining | PubMed |
| Therapeutics candidates and repurposing strategies to target parkinson's disease pathology: current evidence and future directions. | Metab Brain Dis | 2026 | 42714656 | PubTator, text mining | PubMed |
| USP14 competitively binds to FBXW7 to stabilize MTDH and promotes metastasis and drug resistance of head and neck squamous cell carcinoma. | Proc Natl Acad Sci U S A | 2026 | 42616774 | PubTator, text mining | PubMed |
| Zebrafish USP14 suppresses RIG-I-mediated innate antiviral immunity via targeted deubiquitination to facilitate SVCV replication. | Fish Shellfish Immunol | 2026 | 42607976 | PubTator, text mining | PubMed |
| The Dual Roles of Microglia- and Astrocyte-Derived Exosomes in Cerebral Ischemia-Reperfusion Injury: from Intercellular Communication to Therapeutic Prospects. | Mol Neurobiol | 2026 | 42547642 | PubTator, text mining | PubMed |
| VLX1570 suppresses neuroblastoma growth through inhibition of PCNA-associated proliferative signaling and potentiates cisplatin antitumor activity. | Front Pharmacol | 2026 | 42529093 | PubTator, text mining | PubMed |
| USP14 promotes head and neck squamous cell carcinoma progression via deubiquitinating and stabilizing CFL2. | Future Sci OA | 2026 | 42454444 | PubTator, text mining | PubMed |
| Structure-guided design of potent and selective covalent inhibitors of SARS-CoV-1 and SARS-CoV-2 papain-like proteases with antiviral activity. | Eur J Med Chem | 2026 | 42430953 | PubTator, text mining | PubMed |
| The mechanism of deubiquitinase USP14 modifying HSP90AA1 to activate NRF2 signaling in lung cancer cell resistance to ferroptosis. | Mol Biol Rep | 2026 | 42429998 | PubTator, text mining | PubMed |
| Corrigendum to "Mechanistic insights into the role of USP14 in adipose tissue macrophage recruitment and insulin resistance in obesity" [Int. J. Biol. Macromol. 267 (2024) 131645]. | Int J Biol Macromol | 2026 | 42364958 | PubTator, text mining | PubMed |
| Emerging regulatory model of Ubiquitin-Specific Proteases 14 in cancer: from canonical oncogenesis to TME modulation, therapeutic resistance, and non-canonical activities. | J Transl Med | 2026 | 42363186 | PubTator, text mining | PubMed |
| Architectural Refuges: Mapping Spatial Heterogeneity and Niche-Mediated Drug Resistance in Gastric and Esophageal Adenocarcinomas. | Cancers (Basel) | 2026 | 42279331 | PubTator, text mining | PubMed |
| Deubiquitinases at the crossroads of ferroptosis and cancer therapy: mechanisms and therapeutic potential. | Mol Biol Rep | 2026 | 42171907 | PubTator, text mining | PubMed |
| Androgen receptor splice variant 7 (AR-V7) in castration-resistant prostate cancer: Molecular mechanisms and therapeutic strategies. | Urol Oncol | 2026 | 42115122 | PubTator, text mining | PubMed |
| ADORA2B, deubiquitinated by USP14, facilitates IL-1β-induced chondrocyte apoptosis, ferroptosis and inflammation to accelerate osteoarthritis process. | Medicine (Baltimore) | 2026 | 42071882 | PubTator, text mining | PubMed |
| b-AP15 enhances TRAIL-induced cell death in HNSCC via the induction of ROS/JNK/DR5 signalling. | Cancer Gene Ther | 2026 | 42069980 | PubTator, text mining | PubMed |
| Targeting USP14 enhances immunotherapy response by reprogramming tumor-associated macrophages in colon cancer. | iScience | 2026 | 42058892 | PubTator, text mining | PubMed |
| [Impact of house dust mite subcutaneous immunotherapy on plasma protein profiles in children with asthma]. | Zhonghua Yi Xue Za Zhi | 2026 | 42049523 | PubTator, text mining | PubMed |
| Regulation of sepsis-associated acute kidney injury by ELAVL1 through USP14/NCOA4-mediated ferroptosis in renal tubular epithelial cells. | Mol Cell Biochem | 2026 | 42043768 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9097/papers